By TGaS Advisors, LLC

closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2014 via Company Press Release

TGaS Advisors, LLC, acquired TGaS Advisors, LLC

synopsis: TGaS® Advisors, the premier provider of benchmarking and advisory services to the commercial operations organizations of pharmaceutical and biotechnology companies, has been acquired by Trientis Vitae, a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. TGaS had been owned by ABRY Partners since 2010.
buyer parent: Geminin Investors, LLC
buyer: TGaS Advisors, LLC
Trientis Vitae is a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. The buyout was sponsored by Gemini Investors which led a consortium of investors including Triangle Capital Corporation, Tregaron Capital Company and Salem Investment Partners. "
target parent: ABRY Partners, LLC
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2010 via Company Press Release

KnowledgePoint360 Group, LLC, acquired TGaS Advisors, LLC

synopsis: KnowledgePoint360 Group, a global leader in communications and information services for healthcare professionals, has acquired TGaS Advisors, LLC, the premier provider of benchmark-based advisory services to the pharma and biotech industry.
buyer parent: ABRY Partners
buyer: KnowledgePoint360 Group, LLC
KnowledgPoint360 provides a broad range of medical communications services, including medical education, publication support, live educational meetings, scientific content development, exhibit design, digital solutions, training, workflow and compliance solutions. "
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/4/2019 via BusinessWire

Pharmerit International merged with Open Health,

synopsis: OPEN Health, a leading multi-disciplinary health communications and market access group, has merged with Pharmerit International, LP, the largest independent global provider of health economics and outcomes research and strategic market access services to the pharmaceutical industry.
buyer parent: Amulet Capital Partners LP
buyer: Open Health
OPEN Health is a multi-disciplinary health communications and market access group, operating across three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. "
target: Pharmerit International
Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in HEOR and market access worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2018 via Company Press Release

The WIRB-Copernicus Group, acquired KMR Group

synopsis: WIRB-Copernicus Group (WCG), the leading provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired KMR Group, a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: KMR Group
KMR Group is a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry. KMR offers leading-edge data, products, and services in the form of reports and on-line tools that inform client strategy and productivity as well as day-to-day operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2018 via PR Newswire

ZS Associates, purchased BASES Pharmaceutical Forecasting from The Nielsen Company, Inc.

synopsis: ZS announced it has acquired the assets of BASES Pharmaceutical Forecasting from Nielsen. The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
buyer: ZS Associates
ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. Founded in 1983, ZS has grown into a firm of 500 professionals delivering expertise across much of the sales and marketing spectrum. "
seller: The Nielsen Company, Inc. (NLSN:$6,618.00)
The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/10/2014 via Company Press Release

Cello Group, acquired Promedica, Inc

synopsis: Cello Group plc, the healthcare and consumer strategic marketing group, is pleased to announce the acquisition of Worldwide Promedica Inc. Promedica is a San Francisco based market research firm serving pharmaceutical and biotechnology companies.
buyer: Cello Group (AIM:CLL:$204.91)
Cello is a leading global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors in addition to deep expertise in a range of other high margin sectors. "
target: Promedica, Inc
Promedica’s mission is to provide primary marketing research in the area of new product planning with an exclusive focus on healthcare, and a client-side perspective. Their ultimate goal is to optimize client's marketing research investment and contribute to company’s success.
price ($mm)
$0.70
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.3x
EV / EBITDA
closed 11/20/2014 via Company Press Release

TGaS Advisors, LLC, acquired TGaS Advisors, LLC

synopsis: TGaS® Advisors, the premier provider of benchmarking and advisory services to the commercial operations organizations of pharmaceutical and biotechnology companies, has been acquired by Trientis Vitae, a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. TGaS had been owned by ABRY Partners since 2010.
buyer parent: Geminin Investors, LLC
buyer: TGaS Advisors, LLC
Trientis Vitae is a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. The buyout was sponsored by Gemini Investors which led a consortium of investors including Triangle Capital Corporation, Tregaron Capital Company and Salem Investment Partners. "
target parent: ABRY Partners, LLC
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2013 via BusinessWire

Audax Group, acquired Chesapeake Research Review

synopsis: Audax Group announced it has completed the recapitalization of Chesapeake Research Review, Inc. Chesapeake is a leading provider of independent institutional review board (“IRB”) services to major pharmaceutical, biotech and medical device companies, universities, academic medical centers, and hospital systems.
buyer: Audax Group
Audax Group, founded in 1999, is a leading investor in lower-middle market companies. With offices in Boston and New York, Audax has over $5 billion in assets under management in its Private Equity, Mezzanine, and Senior Debt businesses. "
target: Chesapeake Research Review
Chesapeake Research Review, Inc. provides human research protections services. It offers institutional review board services & human research protections consultation, including strategic & operational, IRB consultation services; ethical, scientific & applied bioethics review, education & auditing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2012 via PR Newswire

McCann Health, acquired Double Helix

synopsis: McCann Health announced the acquisition of Double Helix. Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Health
Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. "
target: Double Helix
Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in 1995, they have been providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2012 via Market Wire

ImpactRx, Inc., acquired Source Healthcare Analytics, LLC

synopsis: Symphony Technology Group announced that it has acquired Source Healthcare Analytics, LLC. STG will combine Source Healthcare Analytics with ImpactRx to form Symphony Health Solutions, which will be focused on delivering high-value data, analytics, and technology based solutions for clients across life science manufacturers, payers, and providers.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target parent: Wolters Kluwer NV
target: Source Healthcare Analytics, LLC
Source Healthcare Analytics is a leading provider of information and analytics to the pharmaceutical, biotech and financial industries. The company's brands include Source®, ProMetis™ and inThought™.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2011 via BNC Analysis

Market Probe, acquired Richard Day Research Inc.

synopsis: Market Probe has announced the acquisition of Richard Day Research Inc. (RDR), a specialist in financial services and pharmaceutical research based in Evanston, IL. RDR employs a range of methods from quantitative surveys of clients and prospects, to internal analyses of customer databases.
buyer: Market Probe
Market Probe is a global market research firm providing full-service strategic guidance and business solutions to major international companies. It specializes in customer satisfaction, employee and brand stakeholder marketing research, with in-house facilities for field services by Web and phone. "
target: Richard Day Research Inc.
Richard Day Research Inc. is a specialist in financial services and pharmaceutical research based in Evanston, IL. Its specialties include advanced analytics, brand support, data collection, general public surveys, marketing effectiveness & win/loss, qualitative research, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2011 via BNC Analysis

LA-SER Alpha Group Sarl, will acquire Analytica International, Inc.

synopsis: Accentia Biopharmaceuticals, Inc. announced that it has entered into an agreement to sell the assets of its non-strategic business unit, Analytica International, Inc., a healthcare economics consulting firm to LA-SER, a London-based pharma research company.
buyer: LA-SER Alpha Group Sarl
LA-SER was founded in 2004, with a mission to bring cutting-edge scientific methodology to evaluate the real-world impact of medicines. Their goal is to find for whom and under which conditions of use the drugs will demonstrate best benefit to patients, with minimal harm. "
target parent: Accentia Biopharmaceuticals, Inc.
target: Analytica International, Inc.
Analytica Group, Inc., a healthcare consultancy firm, provides pharmaceutical research and analysis solutions.
price ($mm)
$4.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2011 via BNC Analysis

IMS Health Incorporated, acquired SDI Health LLC

synopsis: IMS Health has completed its acquisition of SDI, a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations. "
target parent: LLR Partners
target: SDI Health LLC
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
$340
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2010 via Company Press Release

KnowledgePoint360 Group, LLC, acquired TGaS Advisors, LLC

synopsis: KnowledgePoint360 Group, a global leader in communications and information services for healthcare professionals, has acquired TGaS Advisors, LLC, the premier provider of benchmark-based advisory services to the pharma and biotech industry.
buyer parent: ABRY Partners
buyer: KnowledgePoint360 Group, LLC
KnowledgPoint360 provides a broad range of medical communications services, including medical education, publication support, live educational meetings, scientific content development, exhibit design, digital solutions, training, workflow and compliance solutions. "
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,296.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/16/2009 via PR Newswire

Knowledge Networks, acquired Caduceus Marketing Research

synopsis: Knowledge Networks is significantly expanding its position in the pharmaceutical and bio-tech research market with the acquisition of Caduceus Marketing Research (CMR). Over the past 11 years CMR has built and grown a panel, the Physicians Consulting Network, which now includes 70,000 U.S. physicians, and allied healthcare professionals.
buyer: Knowledge Networks
Knowledge Networks specializes in solving complex, high-impact problems. They work closely with clients to create healthy consumer-brand connections, effective marketing and advertising, sound public policies, and accurate social science research. "
target: Caduceus Marketing Research
Caduceus Marketing Research are specialists in quantitative healthcare marketing research. Managed by trained pharmacists of combined healthcare marketing research experience their research includes pharmaceuticals, OTCs, medical devices, surgical supplies,and animal health.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2009 via BusinessWire

IntrinsiQ, acquired WWMR, Inc.

synopsis: IntrinsiQ, the company improving the quality and understanding of cancer care, announced the acquisition of market research and consulting firm WWMR, Inc. The combination creates the single, go-to source for pharmaceutical companies seeking to understand the true drivers behind physicians’ cancer treatment decisions.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: IntrinsiQ
IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each month, IntrinsiQ’s clinical software application, IntelliDose®, captures the treatment decisions and details for nearly 20,000 unique patients. "
target: WWMR, Inc.
WWMR is a marketing research and strategic consulting firm founded in 1994, providing insightful, proprietary studies to pharmaceutical, biotech, medical device, and diagnostics companies worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/4/2019 via BusinessWire

Pharmerit International merged with Open Health,

synopsis: OPEN Health, a leading multi-disciplinary health communications and market access group, has merged with Pharmerit International, LP, the largest independent global provider of health economics and outcomes research and strategic market access services to the pharmaceutical industry.
buyer parent: Amulet Capital Partners LP
buyer: Open Health
OPEN Health is a multi-disciplinary health communications and market access group, operating across three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. "
target: Pharmerit International
Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in HEOR and market access worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2018 via Company Press Release

The WIRB-Copernicus Group, acquired KMR Group

synopsis: WIRB-Copernicus Group (WCG), the leading provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired KMR Group, a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: KMR Group
KMR Group is a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry. KMR offers leading-edge data, products, and services in the form of reports and on-line tools that inform client strategy and productivity as well as day-to-day operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2018 via PR Newswire

ZS Associates, purchased BASES Pharmaceutical Forecasting from The Nielsen Company, Inc.

synopsis: ZS announced it has acquired the assets of BASES Pharmaceutical Forecasting from Nielsen. The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
buyer: ZS Associates
ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. Founded in 1983, ZS has grown into a firm of 500 professionals delivering expertise across much of the sales and marketing spectrum. "
seller: The Nielsen Company, Inc. (NLSN:$6,618.00)
The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/10/2014 via Company Press Release

Cello Group, acquired Promedica, Inc

synopsis: Cello Group plc, the healthcare and consumer strategic marketing group, is pleased to announce the acquisition of Worldwide Promedica Inc. Promedica is a San Francisco based market research firm serving pharmaceutical and biotechnology companies.
buyer: Cello Group (AIM:CLL:$204.91)
Cello is a leading global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors in addition to deep expertise in a range of other high margin sectors. "
target: Promedica, Inc
Promedica’s mission is to provide primary marketing research in the area of new product planning with an exclusive focus on healthcare, and a client-side perspective. Their ultimate goal is to optimize client's marketing research investment and contribute to company’s success.
price ($mm)
$0.70
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.3x
EV / EBITDA
closed 11/20/2014 via Company Press Release

TGaS Advisors, LLC, acquired TGaS Advisors, LLC

synopsis: TGaS® Advisors, the premier provider of benchmarking and advisory services to the commercial operations organizations of pharmaceutical and biotechnology companies, has been acquired by Trientis Vitae, a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. TGaS had been owned by ABRY Partners since 2010.
buyer parent: Geminin Investors, LLC
buyer: TGaS Advisors, LLC
Trientis Vitae is a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. The buyout was sponsored by Gemini Investors which led a consortium of investors including Triangle Capital Corporation, Tregaron Capital Company and Salem Investment Partners. "
target parent: ABRY Partners, LLC
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2013 via BusinessWire

Audax Group, acquired Chesapeake Research Review

synopsis: Audax Group announced it has completed the recapitalization of Chesapeake Research Review, Inc. Chesapeake is a leading provider of independent institutional review board (“IRB”) services to major pharmaceutical, biotech and medical device companies, universities, academic medical centers, and hospital systems.
buyer: Audax Group
Audax Group, founded in 1999, is a leading investor in lower-middle market companies. With offices in Boston and New York, Audax has over $5 billion in assets under management in its Private Equity, Mezzanine, and Senior Debt businesses. "
target: Chesapeake Research Review
Chesapeake Research Review, Inc. provides human research protections services. It offers institutional review board services & human research protections consultation, including strategic & operational, IRB consultation services; ethical, scientific & applied bioethics review, education & auditing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2012 via PR Newswire

McCann Health, acquired Double Helix

synopsis: McCann Health announced the acquisition of Double Helix. Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Health
Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. "
target: Double Helix
Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in 1995, they have been providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2012 via Market Wire

ImpactRx, Inc., acquired Source Healthcare Analytics, LLC

synopsis: Symphony Technology Group announced that it has acquired Source Healthcare Analytics, LLC. STG will combine Source Healthcare Analytics with ImpactRx to form Symphony Health Solutions, which will be focused on delivering high-value data, analytics, and technology based solutions for clients across life science manufacturers, payers, and providers.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target parent: Wolters Kluwer NV
target: Source Healthcare Analytics, LLC
Source Healthcare Analytics is a leading provider of information and analytics to the pharmaceutical, biotech and financial industries. The company's brands include Source®, ProMetis™ and inThought™.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2011 via BNC Analysis

Market Probe, acquired Richard Day Research Inc.

synopsis: Market Probe has announced the acquisition of Richard Day Research Inc. (RDR), a specialist in financial services and pharmaceutical research based in Evanston, IL. RDR employs a range of methods from quantitative surveys of clients and prospects, to internal analyses of customer databases.
buyer: Market Probe
Market Probe is a global market research firm providing full-service strategic guidance and business solutions to major international companies. It specializes in customer satisfaction, employee and brand stakeholder marketing research, with in-house facilities for field services by Web and phone. "
target: Richard Day Research Inc.
Richard Day Research Inc. is a specialist in financial services and pharmaceutical research based in Evanston, IL. Its specialties include advanced analytics, brand support, data collection, general public surveys, marketing effectiveness & win/loss, qualitative research, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2011 via BNC Analysis

LA-SER Alpha Group Sarl, will acquire Analytica International, Inc.

synopsis: Accentia Biopharmaceuticals, Inc. announced that it has entered into an agreement to sell the assets of its non-strategic business unit, Analytica International, Inc., a healthcare economics consulting firm to LA-SER, a London-based pharma research company.
buyer: LA-SER Alpha Group Sarl
LA-SER was founded in 2004, with a mission to bring cutting-edge scientific methodology to evaluate the real-world impact of medicines. Their goal is to find for whom and under which conditions of use the drugs will demonstrate best benefit to patients, with minimal harm. "
target parent: Accentia Biopharmaceuticals, Inc.
target: Analytica International, Inc.
Analytica Group, Inc., a healthcare consultancy firm, provides pharmaceutical research and analysis solutions.
price ($mm)
$4.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2011 via BNC Analysis

IMS Health Incorporated, acquired SDI Health LLC

synopsis: IMS Health has completed its acquisition of SDI, a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations. "
target parent: LLR Partners
target: SDI Health LLC
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
$340
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2010 via Company Press Release

KnowledgePoint360 Group, LLC, acquired TGaS Advisors, LLC

synopsis: KnowledgePoint360 Group, a global leader in communications and information services for healthcare professionals, has acquired TGaS Advisors, LLC, the premier provider of benchmark-based advisory services to the pharma and biotech industry.
buyer parent: ABRY Partners
buyer: KnowledgePoint360 Group, LLC
KnowledgPoint360 provides a broad range of medical communications services, including medical education, publication support, live educational meetings, scientific content development, exhibit design, digital solutions, training, workflow and compliance solutions. "
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,296.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/16/2009 via PR Newswire

Knowledge Networks, acquired Caduceus Marketing Research

synopsis: Knowledge Networks is significantly expanding its position in the pharmaceutical and bio-tech research market with the acquisition of Caduceus Marketing Research (CMR). Over the past 11 years CMR has built and grown a panel, the Physicians Consulting Network, which now includes 70,000 U.S. physicians, and allied healthcare professionals.
buyer: Knowledge Networks
Knowledge Networks specializes in solving complex, high-impact problems. They work closely with clients to create healthy consumer-brand connections, effective marketing and advertising, sound public policies, and accurate social science research. "
target: Caduceus Marketing Research
Caduceus Marketing Research are specialists in quantitative healthcare marketing research. Managed by trained pharmacists of combined healthcare marketing research experience their research includes pharmaceuticals, OTCs, medical devices, surgical supplies,and animal health.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2009 via BusinessWire

IntrinsiQ, acquired WWMR, Inc.

synopsis: IntrinsiQ, the company improving the quality and understanding of cancer care, announced the acquisition of market research and consulting firm WWMR, Inc. The combination creates the single, go-to source for pharmaceutical companies seeking to understand the true drivers behind physicians’ cancer treatment decisions.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: IntrinsiQ
IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each month, IntrinsiQ’s clinical software application, IntelliDose®, captures the treatment decisions and details for nearly 20,000 unique patients. "
target: WWMR, Inc.
WWMR is a marketing research and strategic consulting firm founded in 1994, providing insightful, proprietary studies to pharmaceutical, biotech, medical device, and diagnostics companies worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

By TGaS Advisors, LLC


read more

TGaS Advisors, LLC

TGaS Advisors, LLC

TGaS Advisors, LLC

read more

Pharmerit International

TGaS Advisors, LLC

KMR Group

The Nielsen Company, Inc.

Promedica, Inc

TGaS Advisors, LLC

Chesapeake Research Review

Double Helix

Source Healthcare Analytics, LLC

Medical Collective Intelligence Co. Ltd.

PharmARC Analytic Solutions Pvt. Ltd.

SDI Health LLC

Richard Day Research Inc.

Analytica International, Inc.

SDI Health LLC

TGaS Advisors, LLC

InforMed Direct

BioTrends Research Group, Inc.

Caduceus Marketing Research

WWMR, Inc.

read more

Pharmerit International

TGaS Advisors, LLC

KMR Group

The Nielsen Company, Inc.

Promedica, Inc

TGaS Advisors, LLC

Chesapeake Research Review

Double Helix

Source Healthcare Analytics, LLC

Medical Collective Intelligence Co. Ltd.

PharmARC Analytic Solutions Pvt. Ltd.

SDI Health LLC

Richard Day Research Inc.

Analytica International, Inc.

SDI Health LLC

TGaS Advisors, LLC

InforMed Direct

BioTrends Research Group, Inc.

Caduceus Marketing Research

WWMR, Inc.

Geography
Matching Companies
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,296.52
EBITDA ($mm)
$167.22
EBIT ($mm)
$114.30
Net Income ($mm)
$25.89
Employees
9000
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,296.52
EBITDA ($mm)
$167.22
EBIT ($mm)
$114.30
Net Income ($mm)
$25.89
Employees
9000
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch